Filing Flows › Health Care › Encompass Health (EHC)
Encompass Health (EHC) earnings and revenue breakdown
Latest: Q3 2026 · 10-Q filed Nov 3, 2026 · Encompass Health (EHC) Q3 2026 earnings results →
Q3 2026 Revenue up 9% year over year to $1.6B · 9¢ of every $1 of revenue kept as net profit · operating margin 17.9%
Encompass Health made $1.6B in Q3 2026 (+9% Y/Y): Inpatient $1.6B, Other $40.4M, Patients $8.0M. Operating margin 17.9%, net earnings $150M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 3, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $1.6B in Q3 2026, up 9% year over year and up 1% from the previous quarter. Medicare was the largest line at 66% of revenue. Medicare added $0.12B year over year (up 13%), 92% of the total change. Other declined 20%.
Operating profit was $0.29B, a 17.9% margin (up 1.4 points year over year). Of the extra revenue versus Q3 2025, 34% reached operating profit, above the 16% margin then. Total costs grew 7% against revenue growth of 9%. Net earnings were $0.15B, up 18% year over year. The effective tax rate was 20.8%.
Operating cash flow was $0.36B (up 34% year over year), 178% of net income including minority interests. Non-cash charges added back $0.10B of depreciation and amortization and $0.01B of share-based compensation. Working capital and other items added $0.05B. Capital expenditures of $0.23B left free cash flow of $0.13B.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 10-Q | Nov 3, 2026 | $1.6B | +9% | 17.9% | $150M | $362M |
| Q2 2026 | 10-Q | Aug 7, 2026 | $1.6B | +10% | 18.1% | $154M | $283M |
| Q1 2026 | 10-Q | May 1, 2026 | $1.6B | +9% | 19.0% | $194M | $313M |
| Q4 2025 | 10-K | Feb 26, 2026 | $1.5B | +10% | 18.3% | $146M | $346M |
| Q3 2025 | 10-Q | Oct 31, 2025 | $1.5B | +9% | 16.5% | $126M | $271M |
| Q2 2025 | 10-Q | Aug 6, 2025 | $1.5B | +12% | 17.8% | $142M | $270M |
| Q1 2025 | 10-Q | May 1, 2025 | $1.5B | +11% | 18.3% | $152M | $289M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
Customers and suppliers named in filings
Sells to
- Medicare & Medicaid — 82% of its revenue · Stated in 10-K (sentence) · source
About Encompass Health
We are the nation’s largest owner and operator of inpatient rehabilitation hospitals in terms of patients treated, revenues, and number of hospitals. We provide specialized rehabilitative treatment, using advanced technology and intensive therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence and quality of life. We operate hospitals in 39 states and Puerto Rico, with concentrations in Florida and Texas. As of December 31, 2025, we operated 173 inpatient rehabilitation hospitals. We are committed to delivering high-quality, cost-effective patient care. For 2025, we were named America’s Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista and ranked among Fortune’s World’s Most Admired Companies™ and Forbes’ Most Trusted Companies in America.
In its own words, from its 10-K, filed Feb 26, 2026.
Encompass Health against its Services-Hospitals peers
The largest companies of the same SEC industry, each at its latest quarter.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| EHC Encompass Health | Q3 2026 | $1.6B | +9% | 17.9% |
| MD Pediatrix Medical Group | Q3 2026 | $501M | +2% | 13.0% |
Source: Encompass Health 10-Q on SEC EDGAR · CIK 785161 · Services-Hospitals
Guidance and outlook
13F: who owns EHC and who is buying
More on EHC
- How Encompass Health makes money: revenue by segment
- Encompass Health next earnings date and what analysts expect
- Encompass Health stock forecast, price target and fair value
- Who owns Encompass Health stock: holders, funds and Congress trades
- Encompass Health guidance and outlook
- Encompass Health recalls, complaints and regulation
History
Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results
- Encompass Health guidance history: guided vs reported
- Encompass Health operating margin by quarter
- Encompass Health net income by quarter
- Encompass Health free cash flow by quarter
- Encompass Health capital expenditures by quarter
- Encompass Health Inpatient revenue by quarter
- Encompass Health Patients revenue by quarter